Literature DB >> 8726866

Studies in sheep examining plasma follistatin elevations due to frequent blood sampling or surgery.

R Klein1, D M Robertson, I J Clarke.   

Abstract

UNLABELLED: This study examined the effects of the anticoagulant heparin on plasma follistatin (FS) concentrations used during blood sampling in Corriedale ewes. Plasma FS concentrations increased acutely (P < 0.01) following a bolus intravenous injection of heparin (3200 U). To determine whether frequent sampling per se can also increase plasma FS concentrations, ewes were sampled using a substitute anticoagulant, ethylenediamine tetraacetic acid. Frequent sampling had no effect on plasma FS concentrations. alpha-2 Macroglobulin concentrations were measured before and after bilateral ovariectomy and sham ovariectomy to determine whether this agent causes an increase in plasma FS concentrations 10-12 h after laparotomy. No differences in plasma alpha-2 macroglobulin concentrations were observed at the time of the observed increase in plasma FS concentrations. IN
CONCLUSION: (1) heparin caused acute elevations in plasma FS concentrations probably by binding to FS, thereby reducing its plasma clearance; (2) rapid blood sampling per se did not elevate plasma FS concentrations; (3) alpha-2 macroglobulin concentrations were not elevated at the same time as plasma FS concentrations 10-12 h after surgery; and (4) the small increase in alpha-2 macroglobulin concentrations before surgery was attributable to a stress-induced response as seen in other species.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726866     DOI: 10.1071/rd9960273

Source DB:  PubMed          Journal:  Reprod Fertil Dev        ISSN: 1031-3613            Impact factor:   2.311


  1 in total

1.  Whole genome expression analysis reveals differential effects of TiO2 nanotubes on vascular cells.

Authors:  Lily Peng; Andrea J Barczak; Rebecca A Barbeau; Yuanyuan Xiao; Thomas J LaTempa; Craig A Grimes; Tejal A Desai
Journal:  Nano Lett       Date:  2010-01       Impact factor: 11.189

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.